Acute Anterior Uveitis Following Intravenous Zoledronic Acid Infusion: A Case Report
Journal of Optometry and Ophthalmology Research · 31.03.2026 · 1-4
DOI: 10.61440/joor.2026.v2.07 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Optometry and Ophthalmology Research, online erschienen am 31.03.2026. Verfasst von Leyla Eryiğit Eroğul.
Abstract (Originalsprache)
Background
Bisphosphonates are widely used in the treatment of osteoporosis and other metabolic bone diseases. Although these drugs are generally well tolerated, ocular inflammatory adverse effects such as conjunctivitis, episcleritis, scleritis, and uveitis have been reported. Case Presentation: We report a case of acute anterior uveitis that developed shortly after intravenous zoledronic acid infusion. The patient presented with ocular pain, redness, photophobia, and decreased vision. Slit-lamp examination revealed conjunctival hyperemia and anterior chamber inflammation consistent with acute anterior uveitis. The patient was treated with topical corticosteroids and cycloplegic agents, resulting in rapid clinical improvement and complete resolution of symptoms.
Conclusion
Acute anterior uveitis is a rare but clinically significant adverse reaction associated with intravenous bisphosphonate therapy. Clinicians should consider drug-induced uveitis in patients presenting with ocular symptoms following zoledronic acid infusion.
Zitieren
APA
Eroğul, L. E. (2026). Acute Anterior Uveitis Following Intravenous Zoledronic Acid Infusion: A Case Report. Journal of Optometry and Ophthalmology Research, 1-4. https://doi.org/10.61440/joor.2026.v2.07
Vancouver
Eroğul LE. Acute Anterior Uveitis Following Intravenous Zoledronic Acid Infusion: A Case Report. Journal of Optometry and Ophthalmology Research. 2026:1-4. doi:10.61440/joor.2026.v2.07
BibTeX
@article{Eroul2026,
author = {Eroğul, Leyla Eryiğit},
title = {Acute Anterior Uveitis Following Intravenous Zoledronic Acid Infusion: A Case Report},
journal = {Journal of Optometry and Ophthalmology Research},
year = {2026},
pages = {1--4},
doi = {10.61440/joor.2026.v2.07}
}
EUVIMED